Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02337014
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
C6L | N-hexanoyl-L-homoserine | A | 3DHA | 0.79 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHB | 0.79 | |
NLG | N-ACETYL-L-GLUTAMATE | A | 1OH9 | 0.72 | |
NLG | N-ACETYL-L-GLUTAMATE | A | 1OHA | 0.72 | |
NLG | N-ACETYL-L-GLUTAMATE | A,B,C,D,E,F, G,H,I,J,K,L | 2BUF | 0.72 | |
NLG | N-ACETYL-L-GLUTAMATE | A,B,C,D | 2RD5 | 0.72 | |
NLG | N-ACETYL-L-GLUTAMATE | A,B | 2JJ4 | 0.72 | |
NLG | N-ACETYL-L-GLUTAMATE | A,B,C,D,E,F, G,H,J,K | 2V5H | 0.72 | |
NLG | N-ACETYL-L-GLUTAMATE | A | 1GSJ | 0.72 | |
NLG | N-ACETYL-L-GLUTAMATE | A | 3B8G | 0.72 | |
NLG | N-ACETYL-L-GLUTAMATE | A | 1GS5 | 0.72 | |
NLG | N-ACETYL-L-GLUTAMATE | A,B,C | 2BTY | 0.72 | |
DMH | N4,N4-DIMETHYL-ASPARAGINE | E,F,G,H | 1NKK | 0.76 | |
DMH | N4,N4-DIMETHYL-ASPARAGINE | A,B,C,D,E,F, G,H | 1NJT | 0.76 | |
DMH | N4,N4-DIMETHYL-ASPARAGINE | E,F,G,H | 1NJU | 0.76 | |
DMH | N4,N4-DIMETHYL-ASPARAGINE | Y,Z | 1JQ7 | 0.76 | |
DMH | N4,N4-DIMETHYL-ASPARAGINE | C | 1NKM | 0.76 | |
NCD | N-CARBAMOYL-L-ASPARTATE | A,B | 2Z26 | 0.75 | |
NCD | N-CARBAMOYL-L-ASPARTATE | A,B | 1J79 | 0.75 | |
NCD | N-CARBAMOYL-L-ASPARTATE | A,B | 1XGE | 0.75 | |
NCD | N-CARBAMOYL-L-ASPARTATE | A,B | 2Z29 | 0.75 | |
NCD | N-CARBAMOYL-L-ASPARTATE | A,B,G,H | 1R0C | 0.75 | |
NCD | N-CARBAMOYL-L-ASPARTATE | A,B | 2Z27 | 0.75 | |
NCD | N-CARBAMOYL-L-ASPARTATE | A,B | 2Z28 | 0.75 | |
NCD | N-CARBAMOYL-L-ASPARTATE | A,B | 2Z2A | 0.75 | |
NCD | N-CARBAMOYL-L-ASPARTATE | A,B | 2Z24 | 0.75 | |
NCD | N-CARBAMOYL-L-ASPARTATE | A,B | 2Z25 | 0.75 | |
DOR | (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE- 4-CARBOXYLIC ACID | A,B | 2E68 | 0.72 | |
DOR | (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE- 4-CARBOXYLIC ACID | A,B | 1XGE | 0.72 | |
DOR | (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE- 4-CARBOXYLIC ACID | A,B | 2Z29 | 0.72 | |
DOR | (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE- 4-CARBOXYLIC ACID | A,B | 2Z26 | 0.72 | |
DOR | (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE- 4-CARBOXYLIC ACID | A,B | 2Z27 | 0.72 | |
DOR | (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE- 4-CARBOXYLIC ACID | A,B | 2Z28 | 0.72 | |
DOR | (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE- 4-CARBOXYLIC ACID | A,B | 2Z2A | 0.72 | |
DOR | (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE- 4-CARBOXYLIC ACID | A,B | 2Z24 | 0.72 | |
DOR | (4S)-2,6-DIOXOHEXAHYDROPYRIMIDINE- 4-CARBOXYLIC ACID | A,B | 2Z25 | 0.72 | |
ATI | N-(3-AMINO-2-HYDROXY-5-METHYLHEXANOYL)VALYLVALYLASPARTIC ACID | A | 1Y0Y | 0.7 | |
SMG | N-SUCCINYL METHIONINE | A,B,C,D | 1SJC | 0.74 | |
PAL | N-(PHOSPHONACETYL)-L-ASPARTIC ACID | A,B,C | 1EKX | 0.72 | |
PAL | N-(PHOSPHONACETYL)-L-ASPARTIC ACID | A,B,C,D,E,F, G,H,I,J,K,L | 1Q95 | 0.72 | |
PAL | N-(PHOSPHONACETYL)-L-ASPARTIC ACID | A,B,C,D | 1TTH | 0.72 | |
PAL | N-(PHOSPHONACETYL)-L-ASPARTIC ACID | A,B,C,D | 1ACM | 0.72 | |
PAL | N-(PHOSPHONACETYL)-L-ASPARTIC ACID | A,B,C,D | 1D09 | 0.72 | |
PAL | N-(PHOSPHONACETYL)-L-ASPARTIC ACID | A,B,C,D | 1XJW | 0.72 | |
PAL | N-(PHOSPHONACETYL)-L-ASPARTIC ACID | A | 1ML4 | 0.72 | |
PAL | N-(PHOSPHONACETYL)-L-ASPARTIC ACID | B,D | 1I5O | 0.72 | |
PAL | N-(PHOSPHONACETYL)-L-ASPARTIC ACID | A,B,C,D | 1F1B | 0.72 | |
PAL | N-(PHOSPHONACETYL)-L-ASPARTIC ACID | A,B,C,D | 8ATC | 0.72 | |
OHN | N-3-OXO-DODECANOYL-L-HOMOSERINE LACTONE | E,F,G,H | 2UV0 | 0.71 | |
168 | PANTOTHENYL-AMINOETHANOL-ACETATE PIVALIC ACID | A,B,C,D | 1OU6 | 0.74 | |
193 | (2S)-4-(BETA-ALANYLAMINO)-2-AMINOBUTANOIC ACID | A | 1XY5 | 0.77 | |
AN0 | N-ACETYL-L-NORVALINE | C,D,E,X,Y,Z | 2G7M | 0.71 | |
AN0 | N-ACETYL-L-NORVALINE | A | 1ZQ8 | 0.71 | |
HTF | N-(2-OXOTETRAHYDROFURAN-3-YL)OCTANAMIDE | A | 2AVX | 0.72 | |
NSK | N-SUCCINYL LYSINE | A | 2P8B | 0.77 | |
PAU | PANTOTHENOIC ACID | A,B | 2F9W | 0.71 | |
PAU | PANTOTHENOIC ACID | A,B,C,D,E,F | 3BF1 | 0.71 | |
PAU | PANTOTHENOIC ACID | A,B,C,D | 1SQ5 | 0.71 | |
PAU | PANTOTHENOIC ACID | A,B,C,D,E,F | 3BEX | 0.71 | |
OPI | PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID | A,B,C,D | 2VU1 | 0.74 | |
1IP | N~2~-(PHOSPHONOACETYL)-L-ASPARAGINE | A,B,C,D | 2IPO | 0.77 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PPP | 0.71 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PE6 | 0.71 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1ITO | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B,K,L | 1B8D | 0.79 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P,Q,R, S,T,U,V,W,X | 1GH0 | 0.79 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D | 1XF6 | 0.79 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, H,I,J,K,L,M | 1B33 | 0.79 | |
MEN | N-METHYL ASPARAGINE | A,B | 1I7Y | 0.79 | |
MEN | N-METHYL ASPARAGINE | A,B | 3BRP | 0.79 | |
MEN | N-METHYL ASPARAGINE | A,B | 1JBO | 0.79 | |
MEN | N-METHYL ASPARAGINE | A,B | 1ALL | 0.79 | |
MEN | N-METHYL ASPARAGINE | A,B,K,L | 1EYX | 0.79 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P,Q,R, S,T,U,V,W,X | 1HA7 | 0.79 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D | 2VJH | 0.79 | |
MEN | N-METHYL ASPARAGINE | A,B | 1KTP | 0.79 | |
MEN | N-METHYL ASPARAGINE | A,B | 1PHN | 0.79 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D | 1QGW | 0.79 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D | 1XG0 | 0.79 | |
MEN | N-METHYL ASPARAGINE | A,B | 2VJT | 0.79 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, K,L,M,N,O,P | 2BV8 | 0.79 | |
MEN | N-METHYL ASPARAGINE | A,B | 2V8A | 0.79 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, G,H | 3DBJ | 0.79 | |
DLS | DI-ACETYL-LYSINE | A,B,C,D,E,F | 1FVM | 0.73 | |
LAE | 3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO- FURAN-3-YL)-AMIDE | A,B,C,D | 1L3L | 0.72 | |
LAE | 3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO- FURAN-3-YL)-AMIDE | A,B | 2Q0O | 0.72 | |
76V | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE | A | 2DCB | 0.71 | |
SUO | N~2~-(3-CARBOXYPROPANOYL)-L-ORNITHINE | A,B,C,D | 1YNH | 0.78 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G65 | 0.8 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G6A | 0.8 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G68 | 0.8 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | C,D,E,X,Y,Z | 2FG7 | 0.8 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G6C | 0.8 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | C,D,E,X,Y,Z | 2FG6 | 0.8 | |
THC | N-METHYLCARBONYLTHREONINE | A,B,C | 1A7C | 0.71 | |
THC | N-METHYLCARBONYLTHREONINE | B | 2HR0 | 0.71 | |
THC | N-METHYLCARBONYLTHREONINE | L,P | 2MPA | 0.71 | |
THC | N-METHYLCARBONYLTHREONINE | L,P | 1MPA | 0.71 | |
AA1 | [1-(4-ETHOXY-4-OXOBUTANOYL)HYDRAZINO]ACETIC ACID | I | 2C1E | 0.75 | |
AA1 | [1-(4-ETHOXY-4-OXOBUTANOYL)HYDRAZINO]ACETIC ACID | I | 2C2K | 0.75 | |
NLQ | N~2~-ACETYL-L-GLUTAMINE | A,B,C,D | 2GGH | 0.7 | |
NLQ | N~2~-ACETYL-L-GLUTAMINE | A,B,C,D | 1XPY | 0.7 | |
042 | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-THREONYL-L-ISOLEUCINE | A | 2DC7 | 0.7 | |
0AG | N-(ethoxycarbonyl)-L-leucine | I,J | 1PSA | 0.71 | |
75V | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE | A | 2DCA | 0.72 | |
59A | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN- 2-YL]CARBONYL}-L-ISOLEUCINE | A | 2DC8 | 0.73 | |
6PR | (S)-4-AMINO-4-OXO-3-(2-PHOSPHONOACETAMIDO)BUTANOIC ACID | A,B,C,D | 2H3E | 0.72 |